Psychedelic drugs are not addictive and have promise when it comes to mental health and addiction treatment.
There is a rising movement throughout the United States to legalize some or all entheogens, such as mescaline from certain cacti, the root bark of the iboga plant, and psilocybin from some mushrooms, since some people believe that these substances possess medicinal and spiritual powers.
In 2024, the Board of Supervisors of San Francisco overwhelmingly approved a motion to legalize hallucinogenic substances including psilocybin mushrooms and ayahuasca.
There is a “unmet need” for those who suffer from addiction, anxiety, post-traumatic stress disorder (PTSD), and other mental health illnesses to utilize these plants for medical reasons.